top of page

All Posts

Scientists Are Finally Making Progress Against Alzheimer’s

Aug 10

Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function

Jul 28

Eli Lilly's Kisunla wins FDA nod for new dosing with fewer side effects in Alzheimer's

Jul 9

How Kansas can lead on earlier Alzheimer’s detection and care

Jul 3

A Real and Present Threat to Alzheimer’s Patients

Jun 18

Agency Overreach Leaves Patients Untreated

Jun 10

Alzheimer's disease drug development pipeline: 2025

Jun 3

First FDA-cleared Alzheimer's blood test could make diagnoses faster, more accurate

May 21

FDA clears first blood test for diagnosing Alzheimer’s

May 16

Medicare must ensure access to groundbreaking Alzheimer’s treatments for Nevadans

Nov 27, 2024

Polling Reveals Americans Back Alzheimer's Patients

Nov 27, 2024

Medicare's Patient Registry Is Slowing Alzheimer’s Treatment Access

Nov 22, 2024

Advocates Push Candidates on Alzheimer’s Care

Oct 31, 2024

Bipartisan Majority Believes Medicare Beneficiaries Should Have Access to FDA-approved Early Alzheimer’s Medications the Same Way They Do for All Other Diseases

Oct 10, 2024

Access to new Alzheimer’s treatments bogged down by Medicare policy

Jun 17, 2024

Medicare’s Alzheimer's math is fuzzy -- but critics are missing the bigger picture

May 14, 2024

How donanemab data address the coverage with evidence development questions

Feb 1, 2024

Alzheimer’s Discrimination Continues in More Ways Than One (12/19/23)

Dec 19, 2023

Sue Glick Peschin, Celinda Lake and Neil Newhouse: Americans agree: Medicare's unfair on Alzheimer's treatment

Jun 19, 2023

bottom of page